Co-Diagnostics, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Co-Diagnostics, Inc. reported Cash And Cash Equivalents At Carrying Value of $11.88 million for the year ending 2025.

  • Co-Diagnostics, Inc. showed an increase of +304.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Co-Diagnostics, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 11 years of available data (2015 to 2025), Co-Diagnostics, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 35,056.4%.
  • Historical annual values: Fiscal year 2025: $11.88 million | Fiscal year 2024: $2.94 million | Fiscal year 2023: $14.92 million | Fiscal year 2022: $22.97 million | Fiscal year 2021: $88.61 million | Fiscal year 2020: $42.98 million | Fiscal year 2019: $893.1 thousand | Fiscal year 2018: $950.2 thousand | Fiscal year 2017: $3.53 million | Fiscal year 2016: $998.7 thousand | Fiscal year 2015: $33.8 thousand.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: